MedPath

LACRISERT

LACRISERT

Discontinued
DIN Number

02250624

Drug Class

Human

Market Date

May 25, 2004

Company
HC

bausch & lomb inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02250624
AIG Number0150025001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Product Specifications
Dosage FormInsert
Route of AdministrationOphthalmic
AHFS Classification52:13.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYPROLOSEActive
Strength: 5 MG / INSERT
Monograph: HYPROLOSE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.